News

Pharmaceutical Technology on MSN8h
CirCode Biomed gains clearance from FDA for RNA drug HM2002
HM2002 offers advantages due to its composition of circular RNAs, which provide improved stability and low immunogenicity.
Pharmabiz7h
CirCode Biomed gets US FDA clearance for IND application of HM2002, the world's first circular RNA drug being administrated in patients
CirCode Biomed gets US FDA clearance for IND application of HM2002, the world's first circular RNA drug being administrated in patients: Shanghai, China Monday, June 2, 2025, 18:0 ...
FDA crackdown on off-brand Ozempic products set to take effect, threatening supply and access for many
The supply of GLP-1 drugs for weight loss and diabetes treatment is expected to tighten this week with a federal deadline to ...
Pharmaceutical Technology on MSN5d
FDA grants RMAT designation to AbelZeta’s CAR-T therapy
The US Food and Drug Administration (FDA) has granted regenerative medicine advanced therapy (RMAT) designation to AbelZeta ...
FDA won’t approve COVID shot for healthy, non-elderly population
The Food and Drug Administration will no longer approve COVID-19 vaccines for healthy people under 65 without rigorous trials ...
The New Rational FDA COVID Vaccine Policy is Long Overdue, Says NanoViricides’ Dr. Diwan
SHELTON, CT / ACCESS Newswire / May 22, 2025 / Dr. Anil Diwan, President of NanoViricides, Inc. (NYSE Amer.:NNVC ) (the ...
GeoVax Commends FDA's Shift to Risk-Based COVID-19 Vaccination Guidance
Highlights Critical Role of Multi-Antigen GEO-CM04S1 in Protecting Vulnerable Populations ATLANTA, GA - May 27, 2025 ...
PharmExec11d
FDA Clears Investigational New Drug Application for Ascletis’ Oral IL-17 Inhibitor in Mild-to-Moderate Plaque Psoriasis
Clearance of ASC50 paves the way for a Phase I trial in patients with mild-to-moderate plaque psoriasis.
Ophthalmology Times11d
FDA grants Breakthrough Therapy Designation for Tinlarebant
Belite Bio recently announced the US Food and Drug Administration (FDA) granted Breakthrough Therapy Designation for the ...
Medindia2d
CirCode Biomed Announces FDA Clearance for IND Application of HM2002, the world's first circular RNA drug being administrated in patients
With the first patient administrated on September of 2024 in an investigator initiated trial (IIT), HM2002 is the world's first circular RNA drug ever being used in patients. It r ...